Investment Losses Due to Deteriorating Performance at Equity-Method Affiliates
First written in FY2021-Q2. 9 of 19 entries say "Worsened", first in FY2021-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2019: 2 of 7 companies on the "Worse" side.
10 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Equity-method investment loss 97 92」
The equity-method investment loss declined from ¥97 million in the previous year to ¥92 million, slightly reducing the adverse impact on profit and loss. However, losses continue to be recognized. - 2026-05-12MitigatedEarnings
「(Reference) Equity in earnings (losses) of affiliates Fiscal year ending March 2026 (¥92 million) Fiscal year ending March 2025 (¥97 million)」
The equity-method investment loss narrowed slightly from ¥97 million to ¥92 million, but the company continued to record a loss. - FY2026-H1MitigatedAnnual report
「Equity-method investment loss 51 38」
The equity-method investment loss declined from ¥51 million in the same period of the previous year to ¥38 million, narrowing the impact on profit and loss from deteriorating performance at equity-method affiliates. However, losses continue to be recognized. - FY2025WorsenedAnnual report
「The equity-method investment loss increased from ¥77 million in the previous year to ¥97 million in the current year, expanding the impact on profit and loss from deteriorating performance at equity-method affiliates.」
The equity-method investment loss increased from ¥77 million in the previous year to ¥97 million, expanding the adverse impact on profit and loss. - FY2025-H1WorsenedAnnual report
「Equity-method investment loss 48 51」
The equity-method investment loss increased from ¥48 million in the same period of the previous year to ¥51 million, slightly expanding the adverse impact on profit and loss. - FY2024MitigatedAnnual report
「Equity-method investment loss 174 77」
The equity-method investment loss declined from ¥174 million in the previous year to ¥77 million, reducing the adverse impact on profit and loss. However, losses continue to be recognized. - FY2024-Q3MitigatedAnnual report
「Equity-method investment loss 105 57」
The equity-method investment loss declined from ¥105 million in the same cumulative quarter of the previous year to ¥57 million, narrowing the impact on profit and loss from deteriorating performance at equity-method affiliates. However, losses continue to be recognized. - FY2024-Q2WorsenedAnnual report
「Equity-method investment loss 24 48」
The equity-method investment loss increased from ¥24 million in the same quarter of the previous year to ¥48 million, expanding the adverse impact on profit and loss from equity-method affiliates. - FY2024-Q1WorsenedAnnual report
「Equity-method investment loss 2 26」
The equity-method investment loss increased from ¥2 million in the same quarter of the previous year to ¥26 million in the first quarter, expanding the adverse impact on profit and loss from equity-method affiliates. - FY2023WorsenedAnnual report
「Equity-method investment loss 82 174」
The equity-method investment loss increased from ¥82 million in the previous year to ¥174 million in the current year, expanding the impact on profit and loss from deteriorating performance at equity-method affiliates. - FY2023-Q3WorsenedAnnual report
「Equity-method investment loss 79 105」
The equity-method investment loss increased from ¥79 million in the same cumulative quarter of the previous year to ¥105 million, expanding the losses recognized due to deteriorating performance at equity-method affiliates. - FY2023-Q2MitigatedAnnual report
「Equity-method investment loss 37 24」
The equity-method investment loss declined from ¥37 million in the same quarter of the previous year to ¥24 million. Although losses continue to be recognized, the impact on profit and loss has narrowed year on year. - FY2023-Q1MitigatedAnnual report
「Equity-method investment loss 20 2」
The equity-method investment loss declined from ¥20 million in the same quarter of the previous year to ¥2 million, reducing the impact on profit and loss from deteriorating performance at equity-method affiliates in the current quarter. - FY2022MitigatedAnnual report
「Equity-method investment loss 86 82」
The equity-method investment loss declined slightly from ¥86 million in the previous year to ¥82 million, but losses continue to be recognized. - FY2022-Q3WorsenedAnnual report
「Equity-method investment loss 44 79」
The equity-method investment loss increased from ¥44 million in the same cumulative quarter of the previous year to ¥79 million, expanding the losses recognized due to deteriorating performance at equity-method affiliates. - FY2022-Q2RestatedAnnual report
「Equity-method investment loss 30 37」
The equity-method investment loss increased from ¥30 million in the same quarter of the previous year to ¥37 million for the cumulative second quarter, and losses continued to be recognized. - FY2021WorsenedAnnual report
「Ordinary profit was ¥5 million, as the company recognized an equity-method investment loss of ¥86 million, compared with an ordinary loss of ¥146 million in the previous consolidated fiscal year.」
Investment losses associated with deteriorating performance at equity-method affiliates increased from ¥44 million for the cumulative period through the previous quarter to ¥86 million for the full year. - FY2021-Q3WorsenedAnnual report
「Ordinary profit and loss was affected by deteriorating operating profit and loss and, due to the impact of COVID-19, deteriorating performance at equity-method affiliates, causing the equity-method investment gain recognized in the same period of the previous year to turn into a loss, although」
The deterioration in the performance of equity-method affiliates due to the impact of COVID-19 has continued, and the equity-method investment loss is ¥44 million. - FY2021-Q2First statedAnnual report
「In addition, the performance of equity-method affiliates deteriorated due to the impact of COVID-19, and the equity-method investment gain recognized in the same period of the previous year turned into a loss, resulting in an ordinary loss of ¥341 million, a deterioration of ¥27 million year on year.」
The performance of equity-method affiliates deteriorated due to the impact of COVID-19, and the ¥53 million equity-method investment gain in the same period of the previous year turned into a ¥30 million equity-method investment loss in the current period.